Edition:
United Kingdom

Beijing Tiantan Biological Products Corp Ltd (600161.SS)

600161.SS on Shanghai Stock Exchange

25.58CNY
2:41am GMT
Change (% chg)

¥-0.04 (-0.16%)
Prev Close
¥25.62
Open
¥25.56
Day's High
¥25.75
Day's Low
¥25.45
Volume
1,101,248
Avg. Vol
7,308,201
52-wk High
¥39.60
52-wk Low
¥23.85

Chart for

About

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): ¥22,026.41
Shares Outstanding(Mil.): 670.11
Dividend: 0.23
Yield (%): 0.70

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Beijing Tiantan Biological Products unit buys three blood products firms

Jan 19Beijing Tiantan Biological Products Corp Ltd

19 Jan 2018

BRIEF-Beijing Tiantan Biological Products' Controlling Shareholder To Increase Holdings

Dec 19 Beijing Tiantan Biological Products Corp Ltd:

19 Dec 2017

BRIEF-Beijing Tiantan Biological Products' share trade to resume after amending acquisition plan

Dec 13 Beijing Tiantan Biological Products Corp Ltd:

13 Dec 2017

BRIEF-Beijing Tiantan Biological Products' unit to buy stakes in 3 firms for 2.7 bln yuan

Dec 1 Beijing Tiantan Biological Products Corp Ltd:

01 Dec 2017

BRIEF-Beijing Tiantan Biological Products' share trade to halt pending announcement

Oct 16 Beijing Tiantan Biological Products Corp Ltd

16 Oct 2017

BRIEF-Beijing Tiantan Biological Products sees 9-month net profit rise 483 pct y/y

Oct 10 Beijing Tiantan Biological Products Corp Ltd

10 Oct 2017

Earnings vs. Estimates